COVID-19 Phase 3 Assess Efficacy of Ruxolitinib
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Incyte Corporation
Start Date
May 1, 2020
End Date
December 28, 2021
Administered By
Duke Cancer Institute
Awarded By
Incyte Corporation
Start Date
May 1, 2020
End Date
December 28, 2021